CTC Bio (060590.KQ) Stock Price

CTC Bio Price

CLOSED
2,855.00
​
Market closed

Over the last 19 years CTC Bio grew revenue by 5.5% annually, reaching 123.77 B KRW. Earnings per share have grown at 3.4% per year over the last 19 years. For CTC Bio, the net margin of 2.6% is up versus -5.2% a few years ago. At today's price the dividend yield works out to roughly 2.27%. The payout ratio is around 33% of earnings. The dividend has grown at 26.0% per year over the past 3 years.

CTC Bio stock price

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

CTC Bio business model & stock analysis

CTC Bio, Inc. engages in the manufacture of pharmaceuticals, functional food and animal health products. The company is headquartered in Hwaseong, Gyeonggi-Do. The company went IPO on 2002-02-21. The company pharmaceuticals include anticancer agents, antibiotics, bone injury treatments, antiulcer agents, blood flow stimulants and others. Its veterinary drugs include vaccines, antibiotics, immune enhancers, enzymes, organic acid, avian influenza-related agents and others. Its animal feed supplements include pigments, kapok seed meal, sesame meal and others. Its functional food business includes the development and manufacture of enzymes, lactobacillus and related products mainly used in dairy products. The company also involves in the development of pharmaceutical manufacturing technology and know-how. The firm distributes its products within domestic market and to overseas markets.

Frequently asked questions about CTC Bio

5 analysts currently rate the CTC Bio stock: 4 recommend buying, 1 holding and 0 selling.

Converted at the current exchange rate, the CTC Bio share trades at 1.91 EUR (2,855.00 KRW).

The revenue cannot currently be calculated for CTC Bio.

The profit cannot currently be calculated for CTC Bio.

The P/E ratio cannot be calculated for CTC Bio at the moment.

The P/S cannot be calculated for CTC Bio currently.

The Eulerpool Quality Score for CTC Bio is 3/10.

The ISIN of CTC Bio is KR7060590007. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The ticker of CTC Bio is 060590.KQ. The ticker symbol is used to trade CTC Bio shares on the stock exchange.

Fair ValueTerminal
2,712.25 KRW
Over-/UndervaluationTerminal
Fairly valued
Sector
Industry
Pharmaceuticals
Number of shares
Employees
Revenue growth Ø5 years
EBIT growth Ø5 years
Net Income growth Ø5 years
Website ctcbio.com
Country
South Korea
Currency
KRW
Initial public offering
Feb 21, 2002
ISIN
KR7060590007
Cusip
Y1823B101
Market capitalization
68.26 B KRWLarge Cap
52-Week Range
PEG
—
P/E ratio
P/Ee
—
P/S
P/Se
—
EV/EBIT
9.71
P/B Ratio
0.94
ROE (Return on Equity)
ROA (Return on Assets)
ROCE (Return on Capital Employed)
ROIC (Return on Invested Capital)
3.96 %
Dividend
Dividend yield
0.00 %
Payout Ratio
33.92 %
Dividend growth Ø5Y
—
Dividend payments per year
1
Dividend paid since
0 years
Dividend not reduced since
0 years
Dividend increased since
0 years
Dividend withholding tax
22.00 %
Last updated Oct 20, 2026, 4:33 PM

CTC Bio Peer Group

CTC Bio FIGI

060590:KS · BBG000LKKMM6060590:KQ · BBG000LKKPC0

All fundamentals and in-depth analysis of CTC Bio

Our stock analysis for CTC Bio stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of CTC Bio. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.